The Relationship Between Brain Macrophages and Cognitive Dysfunction in Systemic Lupus Erythematosus
系统性红斑狼疮脑巨噬细胞与认知功能障碍的关系
基本信息
- 批准号:10504828
- 负责人:
- 金额:$ 79.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-05 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AgingAlzheimer&aposs DiseaseAmyotrophic Lateral SclerosisAutopsyBehaviorBehavioralBiometryBiopsyBloodBone MarrowBrainCASP8 geneCellsCellular Indexing of Transcriptomes and Epitopes by SequencingCerebrospinal FluidClinicalDataDefectDevelopmentDiagnosisDiagnosticDiagnostic testsDisciplineDiseaseDisease associated microgliaDisease remissionEnvironmental Risk FactorEthicsExhibitsGene Expression ProfileGene Expression ProfilingGenesGeneticGenetic TranscriptionHeadHeterogeneityHippocampus (Brain)HumanIFNAR1 geneITGAX geneImmunologyImpaired cognitionIn VitroIndividualInterferon Type IInterferonsInvestigationLaboratoriesLinkLiteratureMacrophage Colony-Stimulating Factor ReceptorMediator of activation proteinMicrogliaModelingMolecularMusNeuropsychiatric Systemic Lupus ErythematosusOutcomePTPRC genePathogenesisPathogenicityPathologyPathway interactionsPatient-Focused OutcomesPatientsPhagocytesPhagocytosisPlayPopulationPredispositionPublicationsPublishingQuality of lifeReceptor SignalingResearchRoleSamplingSeveritiesSignal TransductionSignaling ProteinSphingosine-1-Phosphate ReceptorSystemic Lupus ErythematosusSystemic diseaseTREM2 geneTarget PopulationsTestingTimeTissuesTranscendTreatment Side EffectsTumor-infiltrating immune cellsUniversitiesagedantagonistbehavioral outcomebrain cellchronic autoimmune diseasecomorbiditydiagnostic strategyeffective therapyexperiencehealth related quality of lifeimprovedinnovationmacrophagemonocytemouse modelneuroimmunologynovelnovel therapeuticsperipheral bloodpreventprogramsreceptorsingle-cell RNA sequencingsynaptic pruningsystemic autoimmunitytargeted treatmenttranscriptome sequencing
项目摘要
Northwestern University
PROJECT SUMMARY
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease involving genetic and environmental
factors culminating in multiple detrimental comorbidities. One such comorbidity is the onset of what is referred
to as CNS lupus (NP-SLE). Despite the impact of NP-SLE on health-related quality of life and although numerous
mechanisms have been proposed, none can solely account for NP-SLE pathogenesis. We published that
expression of NP-SLE-specific disease signatures in tissue-resident macrophages in the brain correlates with
the severity of behavioral deficits in two NP-SLE models prior to overt systemic disease. Further, our single-cell
RNA sequencing (scRNA-seq) data identify homeostatic and disease-associated states in tissue-resident
macrophages of aged control and NP-SLE-prone mice. However, the disease-associated macrophage subset
in NP-SLE is depleted for genes associated with phagocytosis, which is in contrast to their known phagocytic
role in other diseases. We also find that restricted expression of the disease-associated transcriptional program
in NP-SLE tissue-resident macrophages corresponds to improved behavioral outcomes in NP-SLE-prone mice
following treatment with fingolimod. These discoveries mark the first to implicate this disease-associated tissue-
resident macrophage subset as a potentially pathogenic population in NP-SLE, which contrasts with their
proposed protective role in the literature. We hypothesize that pathogenic disease-associated tissue-
resident macrophages in the brain are crucial for NP-SLE development and targeting this population
may represent a new therapeutic avenue for treating NP-SLE. In Aim 1, we will determine whether tissue-
resident brain cells or infiltrating immune cells are required for NP-SLE using reciprocal head-shielded bone
marrow chimeric mice of WT and NP-SLE-prone donors and recipients. We will test whether blocking transition
from the homeostatic state to the disease-associated state via deletion of TREM2 (a critical functional regulator
of this population) in tissue-resident macrophages prevents NP-SLE. We will delineate the role that type I
interferon (IFN) plays in the development of NP-SLE-like disease by examining the role for the upstream receptor
(IFNAR) and downstream signaling protein IFN regulatory factor 5 (IRF5), which have been linked to SLE
susceptibility, via deletion of these signaling mediators in tissue-resident macrophages. We identified a cell
subset in human cerebrospinal fluid (CSF) that transcriptionally resembles disease-associated tissue-resident
macrophages. Moreover, classical monocytes can repopulate a compromised tissue-resident macrophage niche
and we see numerical expansion of these cells in NP-SLE models. In Aim 2, we will obtain paired CSF and
peripheral blood (PB) from SLE patients with and without NP-SLE for transcriptional profiling of CSF
macrophages and PB monocytes to correlate with clinical outcomes. Despite investigation of tissue-resident
macrophages in the brain in other disciplines, we will be the first to examine their role in NP-SLE. These data
will be invaluable for downstream development of improved diagnostics or targeted therapies.
西北大学
项目概要
系统性红斑狼疮(SLE)是一种慢性自身免疫性疾病,涉及遗传和环境因素
最终导致多种有害合并症的因素。其中一种合并症是所提到的疾病的发作
中枢神经系统狼疮 (NP-SLE)。尽管 NP-SLE 对健康相关的生活质量有影响,并且尽管有许多
虽然已经提出了一些机制,但没有一个可以单独解释 NP-SLE 的发病机制。我们发表了
大脑组织驻留巨噬细胞中 NP-SLE 特异性疾病特征的表达与
两个 NP-SLE 模型在明显的全身性疾病之前行为缺陷的严重程度。此外,我们的单细胞
RNA 测序 (scRNA-seq) 数据可识别组织驻留体内的稳态和疾病相关状态
衰老对照小鼠和易患 NP-SLE 小鼠的巨噬细胞。然而,与疾病相关的巨噬细胞亚群
NP-SLE 中与吞噬作用相关的基因被耗尽,这与它们已知的吞噬作用相反
在其他疾病中的作用。我们还发现与疾病相关的转录程序的限制表达
NP-SLE 组织驻留巨噬细胞中的 NP-SLE 与易患 NP-SLE 小鼠的行为结果改善相对应
使用芬戈莫德治疗后。这些发现标志着第一个涉及这种疾病相关组织的发现
常驻巨噬细胞亚群作为 NP-SLE 中的潜在致病群体,这与其
文献中提出的保护作用。我们假设与致病性疾病相关的组织
大脑中常驻的巨噬细胞对于 NP-SLE 的发展和针对该人群至关重要
可能代表治疗 NP-SLE 的新治疗途径。在目标 1 中,我们将确定组织是否-
使用交互头部屏蔽骨的 NP-SLE 需要常驻脑细胞或浸润免疫细胞
WT 和 NP-SLE 易感供体和受体的骨髓嵌合小鼠。我们将测试是否阻塞转换
通过删除 TREM2(一种关键的功能调节因子)从稳态到疾病相关状态
组织驻留巨噬细胞中的该人群的人)可预防 NP-SLE。我们将描述 I 类角色
通过检查上游受体的作用,干扰素 (IFN) 在 NP-SLE 样疾病的发展中发挥作用
(IFNAR) 和下游信号蛋白 IFN 调节因子 5 (IRF5),与 SLE 相关
通过删除组织驻留巨噬细胞中的这些信号传导介质来提高易感性。我们识别出一个细胞
人类脑脊液 (CSF) 中的子集,其转录类似于疾病相关组织驻留
巨噬细胞。此外,经典单核细胞可以重新填充受损的组织驻留巨噬细胞生态位
我们在 NP-SLE 模型中看到这些细胞的数值扩展。在目标 2 中,我们将获得配对的 CSF 和
患有或不患有 NP-SLE 的 SLE 患者的外周血 (PB),用于 CSF 转录谱分析
巨噬细胞和 PB 单核细胞与临床结果相关。尽管对组织驻留进行了调查
在其他学科中,我们将首先研究大脑中的巨噬细胞在 NP-SLE 中的作用。这些数据
对于改进诊断或靶向治疗的下游开发将具有无价的价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carla M Cuda其他文献
Carla M Cuda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carla M Cuda', 18)}}的其他基金
The Relationship Between Brain Macrophages and Cognitive Dysfunction in Systemic Lupus Erythematosus
系统性红斑狼疮脑巨噬细胞与认知功能障碍的关系
- 批准号:
10659233 - 财政年份:2022
- 资助金额:
$ 79.9万 - 项目类别:
Caspase 8: A Novel Suppressor of Dendritic Cell-Mediated Autoimmunity
Caspase 8:树突状细胞介导的自身免疫的新型抑制剂
- 批准号:
9248789 - 财政年份:2013
- 资助金额:
$ 79.9万 - 项目类别:
Caspase 8: A Novel Suppressor of Dendritic Cell-Mediated Autoimmunity
Caspase 8:树突状细胞介导的自身免疫的新型抑制剂
- 批准号:
8634024 - 财政年份:2013
- 资助金额:
$ 79.9万 - 项目类别:
Caspase 8: A Novel Suppressor of Dendritic Cell-Mediated Autoimmunity
Caspase 8:树突状细胞介导的自身免疫的新型抑制剂
- 批准号:
8487862 - 财政年份:2013
- 资助金额:
$ 79.9万 - 项目类别:
The role of fas signaling in rheumatoid arthritis
fas信号在类风湿性关节炎中的作用
- 批准号:
8324781 - 财政年份:2010
- 资助金额:
$ 79.9万 - 项目类别:
The role of fas signaling in rheumatoid arthritis
fas信号在类风湿性关节炎中的作用
- 批准号:
8326559 - 财政年份:2010
- 资助金额:
$ 79.9万 - 项目类别:
The role of fas signaling in rheumatoid arthritis
fas信号在类风湿性关节炎中的作用
- 批准号:
8003914 - 财政年份:2010
- 资助金额:
$ 79.9万 - 项目类别:
相似国自然基金
基于神经退行性疾病前瞻性队列的新烟碱类杀虫剂暴露对阿尔茨海默病的影响及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
基于miRNA介导ceRNA网络调控作用的防治阿尔茨海默病及认知障碍相关疾病药物的发现研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
LMTK1调控核内体转运介导阿尔茨海默病神经元Reserve机制研究
- 批准号:81903703
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于自组装多肽纳米探针检测蛋白标志物用于阿尔茨海默病精准诊断的研究
- 批准号:31900984
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
靶向干预CD33/Aβ相互作用改善小胶质细胞功能延缓AD病理进程
- 批准号:81901072
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 79.9万 - 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 79.9万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 79.9万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 79.9万 - 项目类别: